UPDATE: Geneva Proteomics Plans Rapid Growth After Signing $84M Novartis Deal | GenomeWeb

NEW YORK, Oct. 17 – After announcing Tuesday it would receive $84 million from Novartis for a five-year proteome analysis project, Geneva Proteomics said it would begin rapidly ramping up its Geneva-based operations immediately and that it plans to open a proteomics factory in Princeton, N.J next year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."